Cytokines and MMP-9 Levels in Rheumatoid Arthritis and Osteoarthritis Patients with Persistent Parvovirus B19, HHV-6 and HHV-7 Infection

Ahrem, M. J., Smith, M. D. (1997). Rheumatoid arthritis. Med. J. Austral.,166, 156–61.Search in Google Scholar

Aletaha, D., Neogi, T., Silman, A., Funovits, J., Felson, D., et al. (2010). Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Arthritis Rheum., 62, 2569–2581.10.1002/art.27584Search in Google Scholar

Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., et al. (1986). The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum., 29, 1039–1049.10.1002/art.1780290816Search in Google Scholar

Altman, R., Alarcón, G., Appelrouth, D., Bloch, D., Borenstein, D., Brandt, K., et al. (1990). The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum., 33, 1601–1610.10.1002/art.1780331101Search in Google Scholar

Altman, R., Alarcón, G., Appelrouth, D., Bloch, D., Borenstein, D., Brandt, K., et al. (1991). The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum., 34, 505–514.10.1002/art.1780340502Search in Google Scholar

Alvarez-Lafuente, R., Fernández-Gutiérrez, B., de Miguel, S., Jover, J. A., Rollin, R., Loza, E., Clemente, D., Lamas, J. R. (2005). Potential relationship between herpes viruses and rheumatoid arthritis: Analysis with quantitative real time polymerase chain reaction. Ann. Rheum. Dis., 64 (9), 1357–1359.10.1136/ard.2004.033514Search in Google Scholar

Arnett, F., Edworthy, S., Bloch, D., et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 31, 315–324.10.1002/art.1780310302Search in Google Scholar

Aslan, B., Serin, M. S., Aslan, G., Kalaci, A., Yanat, A. N., Tezcan, S., Emekdas, G. (1988). Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis. Diagn. Microbiol. Infect. Dis., 60 (4), 381–385.Search in Google Scholar

Barah, F., Vallely, P., Chiswick, M., Cleator, M., Kerr, J. (2001). Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet, 358, 729–730.10.1016/S0140-6736(01)05905-0Search in Google Scholar

Barash, J., Dushnitzki, D., Barak, Y., Miron, S., Hahn, T. (2003). Tumor necrosis factor (TNF) alpha and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children. Immunol. Lett., 88, 109–112.10.1016/S0165-2478(03)00075-0Search in Google Scholar

Beal, S. (2001). Ways to fit a PK model with some data below the quantification limit. J. Pharmacokin. Pharmacodyn., 28 (5), 481–504.10.1023/A:1012299115260Search in Google Scholar

Berenbaum, F. (2013). Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage, 21 (1), 16–21.10.1016/j.joca.2012.11.01223194896Search in Google Scholar

Broccolo, F., Drago, F., Cassina, G., Fava, A., Fusetti, L., Matteoli, B., Ceccherini-Nelli, L., Sabbadini, M. G., Lusso, P., Parodi, A., Malna, M. S. (2013). Selective reactivation of human herpesvirus 6 in patients with auto-immune connective tissue diseases. J. Med. Virol., 85, 1925–1934.10.1002/jmv.2367023983182Search in Google Scholar

Broccolo, F., Fusetti, L., Ceccherini-Nelli, L. (2013). Possible role of human herpesvirus 6 as a trigger of autoimmune disease. Sci. World J.,24, Article ID 867389.Search in Google Scholar

Caselli, E., Zatelli, M. C., Rizzo, R., Benedetti, S., Martorelli, D., Trasforini, G., Cassai, E., degli Uberti, E. C., Di Luca, D., Dolcetti, R. (2012). Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis. PLoS. Path., 8 (10), e1002951.10.1371/journal.ppat.1002951346421523055929Search in Google Scholar

Chapenko, S., Millers, A., Nora, Z., Logina, I., Kukaine, R., Murovska, M. (2003). Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol., 69 (1), 111–117.10.1002/jmv.1025812436486Search in Google Scholar

Colmegna, I., Alberts-Grill, N. (2009). Parvovirus B19: Its role in chronic arthritis. Rheum. Dis. Clin. North. Amer., 35 (1), 95–110.10.1016/j.rdc.2009.03.00419480999Search in Google Scholar

Emery, P. (1994). The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease: The key to preventing disability. Brit. J. Rheumatol., 33 (8), 765–768.Search in Google Scholar

Feldmann, M., Brennan, F. M., Maini, R. N. (1996). Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol., 14, 397–440.10.1146/annurev.immunol.14.1.3978717520Search in Google Scholar

Firestein, G. S. (2009). Rheumatoid arthritis. In: Harris, E. D., Budd, R. C., Genovese, M. C., Firestein, G. S., Sargent, J. S., Sledge, C. B. (eds.). Kelley’s Textbook of Rheumatology. 8^th ed. Saunders Elsevier, Philadelphia, Pa, chap. 9.Search in Google Scholar

Flamand, L., Gosselin, J., D’Addario, M., Hiscott, J., Ablashi, D. V., Gallo, D. C., Menezes, J. (1995). Human herpesvirus 6 induces interleukin-1beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J. Virol., 65, 5105–5110.10.1128/jvi.65.9.5105-5110.1991Search in Google Scholar

Flamand, L., Komaroff, A. L., Arbuckle, J. H., Medveczky, P, G, Ablashi, D, V. (2010). Review, part 1: Human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy. J. Med. Virol.,82 (9), 1560–1568.10.1002/jmv.2183920648610Search in Google Scholar

Franssila, R., Hedman, K. (2006). Infection and musculoskeletal conditions: Viral causes of arthritis. Best Pract. Res. Clin. Rheumatol., 20 (6), 1139–1157.10.1016/j.berh.2006.08.00717127201Search in Google Scholar

Fu, Y., Ishii, K. K., Munakata, Y., Saitoh, T., Kaku, M., Sasaki, T. (2002). Regulation of tumor necrosis factor alpha promoter by human parvovirus B 19 NS1 through activation of AP-1 and AP-2. J. Virol.,76, 5395–5400.10.1128/JVI.76.11.5395-5403.200213703511991968Search in Google Scholar

Gibofsky, A. (2012). Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Amer. J. Manag. Care, 18 (13), S295–S,302.Search in Google Scholar

Gosselin, J., Flamand, L., D’Addario, M., Hiscott, J., Stefanescu, I., Ablashi, D. V., Gallo, R. C., Menezes, J. (1992). Modulatory effects of Epstein–Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J. Immunol., 149, 181–187.Search in Google Scholar

Hayem, F., Hayem, G. (2012). Still’s disease and the mitochondrion: The other face of an old friend? Med. Hypotheses, 79 (2), 136–137.10.1016/j.mehy.2012.04.00922580050Search in Google Scholar

Hemauer, A., Gigler, A., Searle, K., Raab, U., Broliden, K., Wolf, H., Enders, G., Modrow, S. (2000). Seroprevalence of parvovirus B19-infected and uninfected individuals, and in infected pregnant women. J. Med. Virol., 60, 48–55.10.1002/(SICI)1096-9071(200001)60:1<48::AID-JMV9>3.0.CO;2-ESearch in Google Scholar

Hsu, T. C., Tzang, B. S., Huang, C. N., Lee, G. J., Lin, G. Y., Chen, M. C., Tsay, G. J. (2006). Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS –7 epithelial cells. Clin. Exp. Immunol., 144, 152–157.10.1111/j.1365-2249.2006.03023.xSearch in Google Scholar

Isa, A., Lundqvist, A., Lindblom, A., Tolfvenstam, T., Broliden, K. (2007). Cytokine responses in acute and persistent human parvovirus B19 infection. Clin. Exp. Immunol., 147, 419–425.10.1111/j.1365-2249.2006.03286.xSearch in Google Scholar

Isa, A., Norbec, O., Hirbod, T., Lundquist, A., Kasprowicz, P., Bowness, P., Broliden, K., Tolfvenstam. T. (2006). Aberrant cellular immune responses in humans infected persistently with parvovirus B19. J. Med. Virol., 78, 129–133.10.1002/jmv.20514Search in Google Scholar

Kerr, J. R. (2000). Pathogenesis of human parvovirus B19 in rheumatic disease. Ann. Rheum. Dis., 59, 672–683.10.1136/ard.59.9.672Search in Google Scholar

Kerr, J. R. (2016). The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J. Clin. Pathol., 69 (4), 279–291.10.1136/jclinpath-2015-203455Search in Google Scholar

Kerr, J. R., Cunniffe, V. S. (2000). Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection. Rheumatology, 39, 903–908.10.1093/rheumatology/39.8.903Search in Google Scholar

Kerr, J. R., Cunniffe, V. S., Kelleher, P., Coats, A. J., Mattey, D. L. (2004). Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: Negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J. Med. Virol., 74 (1), 147–155.10.1002/jmv.20158Search in Google Scholar

Kerr, J. R., Barah, F., Mattey, D. L., Laing, I., Hopkins, S. J., Hutchinson, I., Tyrell, D. A. (2001). Circulating tumour necrosis factor–α and inter -feron–γ are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J. Gen. Virol., 82, 3011–3019.10.1099/0022-1317-82-12-3011Search in Google Scholar

Khouqeer, R. A. (2017). Viral Arthritis. Available from: http://emedicine.medscape.com/article/335692-overview (accessed 04.04.2019).Search in Google Scholar

Kozireva, S., Zestkova, J., Mikazane, H., Kadisa, A., Kakurina, N., Lejnieks, A., Danilane, I. N., Murovska, M. F. (2008). Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. J. Rheumatol., 35, 1265–1270.Search in Google Scholar

Kumar, A., Perdomo, M. F., Kantele, A., Hedman, L., Hedman, K., Franssila, R. (2015). Granzyme B mediated function of parvovirus B19-specific CD4+ T cells. Clin. Transl. Immunol.,4 (7), e39.10.1038/cti.2015.13Search in Google Scholar

Lee, T. H., Kleinman, S. H., Wen, L., Montalvo, L., Todd, D. S., Wright, D. J., Tobler, Busch, M. P. (2011). Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Trasfusion, 51, 1896–1908.10.1111/j.1537-2995.2010.03035.xSearch in Google Scholar

Lehmann, H. W., Kuhner, L., Beckenlehner, K., Muller-Godeffroy, E., Heide, K. G., Kuster, R., Modrow, S. (2002). Chronic human parvovirus B19 infection in rheumatic disease of children and adolescence. J. Clin. Virol., 25, 135–143.10.1016/S1386-6532(01)00247-5Search in Google Scholar

Lu, J., Zhi, N., Wong, S., Brown, K. E. (2006). Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J. Infect. Dis., 193, 582–590.10.1086/499599Search in Google Scholar

Lusso, P. (2006). HHV-6 and the immune system: Mechanisms of immunomodulation and viral escape. J. Clin. Virol., 37, S4–S10.10.1016/S1386-6532(06)70004-XSearch in Google Scholar

Moffatt, S., Tanaka, N., Tada, K., Nose, M., Nakamura, M., Muraoka, O., et al. (1996). A cytotoxic on-structural protein, NS1, of human parvovirus B19 induces activation of interleukin–6 gene expression. J. Virol., 70, 8485–8491.10.1128/jvi.70.12.8485-8491.19961909398970971Search in Google Scholar

Murai, C., Munakata, Y., Takahashi, Y., Ishii, T., Shibata, S., Murryoi, T., Funato, T., Nakamura, M., Sugamure, K., Sasaki, T. (1999). Rheumatoid arthritis after parvovirus B 19 infection. Ann. Rheum. Dis., 58, 130–132.10.1136/ard.58.2.130175283210343531Search in Google Scholar

Naciute, M., Mieliauskaite, D., Rugiene, R., Maciunaite, G., Mauricas, M., Murovska, M., Girkontaite, I. (2017). Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients. Cytokine, 96, 41–48.10.1016/j.cyto.2017.03.00228288327Search in Google Scholar

Naciute, M., Mieliauskaite, D., Rugiene, R., Nikitenkiene, R., Jancoriene, L., Mauricas, M., Nora-Krukle, Z., Murovska, M., Girkontaite, I. (2016). Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis. J. Gen. Virol., 97 (12), 3302–3312.10.1099/jgv.0.000621520367327902343Search in Google Scholar

Nora-Krukle, Z., Chapenko, S., Logina, I., Millers, A., Platkajis, A., Murovska, M. (2011). Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas), 47 (10), 527–531.10.3390/medicina47100075Search in Google Scholar

Ogawa, E., Otaguro, S., Murata, M., Kainuma, M., Sawayama, Y., Furusyo, N., Hayashi, J. (2008). Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection. J. Infect. Chemother., 14 (5), 377–382.10.1007/s10156-008-0636-XSearch in Google Scholar

Von Poblotzki, A., Gerdes, C., Reischl, U., Wolf, H., Modrow, S. (1996). Lymphoproliferative responses after infection with human parvovirus B19. J Virol., 70, 7327–7330.10.1128/jvi.70.10.7327-7330.1996Search in Google Scholar

Von Poblotzki, A., Gigler, A., Lang, B., Wolf, H., Modrow, S. (1995). Antibodies to parvovirus B19 NS1 protein in infected individuals. Gen. Virol., 76, 19–27.Search in Google Scholar

Ray, N. B., Nieva, D. R., Seftor, E. A., Khalkhali-Ellis, Z., Naides, S. J. (2001). Induction of an invasive phenotype by human parvovirus B19 in normal human synosial fibroblasts. Arthr. Rheum., 7, 1582–1586.10.1002/1529-0131(200107)44:7<1582::AID-ART281>3.0.CO;2-ESearch in Google Scholar

Rogers, C., Scott, L., Reeves, B., Downes, S., Lotery, A., Dick, A., Chakravarthy U. (2018). Serum vascular endothelial growth factor levels in the IVAN trial; Relationships with drug, dosing, and systemic serious adverse events. Ophthalmol, Retina, 2 (2), 118–127.10.1016/j.oret.2017.05.015Search in Google Scholar

Stahl, H. D., Pfeiffer, R., von Salis-Soglio, G., Emmrich, F. (2000). Parvovirus B19 associated mono-and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy. Clin. Rheumatol., 19, 510–511.10.1007/s100670070021Search in Google Scholar

Struyk, L., Hawes, G. E., Dolhain, R. J., van Scherpenzeel, A., Godthelp, B., Breedveld, F. C. (1994). Evidence for selective in vivo expansion of synovial tissue-infiltrating CD4⁺ CD45RO⁺ T lymphocytes on the basis of CDR3 diversity. Int. Immunol., 6, 897–907.10.1093/intimm/6.6.897Search in Google Scholar

Sultanova, A., Cistjakovs, M., Gravelsina, S., Chapenko, S., Roga, S., Cunskis, E., Nora-Krukle, Z., Groma, V., Ventina, I., Murovska, M. (2017). Association of active human herpesvirus-6 (HHV-6) infection with autoimmune thyroid gland diseases. Clin. Microbiol. Infect., 23 (1), 50e1–50e5.10.1016/j.cmi.2016.09.023Search in Google Scholar

Takahashi, Y., Murai, C., Shibata, S, Munakata, Y., Ishii, T., Ishii, K., Saitoh, T., Sawai, T., Sugamura, K., Sasaki, T. (1998). Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 95, 8227–8232.10.1073/pnas.95.14.8227Search in Google Scholar

Takasawa, N., Munakata, Y., Ishii, K. K., Takahashi, Y., Takahashi, M., Fu, Y., Ishii, T., Fujii, H., Saito, T., Takano, H., Noda, T., Suzuki, M., Nose, M., Zolla-Patzner, S., Sasaki, T. (2004). Human parvovirus B19 transgenic mice become susceptible to polyarthritis. J. Immunol., 173 (7), 4675–4683.10.4049/jimmunol.173.7.4675Search in Google Scholar

Tzang, B., Chiu, C., Tsai, C., Lee, Y., Lu, I., Shi, J., Hsu, T. (2009). Effects of human parvovirus B19 VP1 unique region protein on macrophage responses. J. Biomed. Sci., 16, 13.10.1186/1423-0127-16-13Search in Google Scholar

Yoshikawa, T., Fujita, A., Yagami, A., Suzuki, K., Matsunaga, K., Ihira, M., Asano, Y. (2006). Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome. J. Clin. Virol.,37, S92–S96.10.1016/S1386-6532(06)70019-1Search in Google Scholar